Cargando…
Lithium placental passage at delivery and neonatal outcomes: A retrospective observational study
INTRODUCTION: Lithium is an effective mood stabilizer and is widely used as a first-line treatment for bipolar disorder in the perinatal period. Several guidelines have provided clinical advice on dosing strategy (dose reduction versus stop lithium) in the peripartum period to minimize the risk of n...
Autores principales: | Imaz, M.L., Torra, M., Soy, D., Langorh, K., Garcia-Esteve, L., Martin-Santos, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471310/ http://dx.doi.org/10.1192/j.eurpsy.2021.540 |
Ejemplares similares
-
Lithium placental passage at delivery: an observational study
por: Imaz, M.L., et al.
Publicado: (2022) -
Infant exposure to lithium through breast milk
por: Imaz, M.L., et al.
Publicado: (2021) -
Clozapine placental passage at delivery: an update
por: Imaz, M.L., et al.
Publicado: (2022) -
Neonatal Feeding Trajectories in Mothers With Bipolar Disorder Taking Lithium: Pharmacokinetic Data
por: Imaz, Maria Luisa, et al.
Publicado: (2021) -
Point-of-care test for rapid assessment of blood lithium levels in women with bipolar disorder during perinatal period
por: Imaz, M.L., et al.
Publicado: (2022)